| |
Description of results from gynecological examinations
| |
|---|
|
Microorganisms
|
With cervical lesions (Cases)
|
Without cervical lesions (Controls)
|
Totala
n = 132
|
|---|
|
Low grade (CIN I)
|
Intermediate (CIN II)
|
High grade (CIN III or in situ carcinoma)
|
Total
|
|---|
| |
n = 18
|
n = 16
|
n = 28
|
n = 62
|
n = 70
|
|---|
| |
n (%)
|
n (%)
|
n (%)
|
n (%)
|
n (%)
|
n (%)
|
|---|
|
PCR
|
|
HPV
|
|
Positive
|
13 (72.2)
|
14 (87.5)
|
26 (92.9)
|
53 (85.5)
|
18 (25.7)
|
71 (53.8)
|
|
Negative
|
5 (27.8)
|
2 (12.5)
|
2 (7.1)
|
9 (14.5)
|
52 (74.3)
|
61 (46.2)
|
|
Mollicutes
|
|
Positive
|
18 (100.0)
|
14 (87.5)
|
25 (89.3)
|
57 (91.9)
|
48 (68.6)
|
105 (79.5)
|
|
Negative
|
0 (0.0)
|
2 (12.5)
|
3 (10.7)
|
5 (8.1)
|
22 (31.4)
|
27 (20.5)
|
|
U. urealyticum
|
|
Positive
|
1 (5.6)
|
3 (18.8)
|
1 (3.6)
|
5 (8.1)
|
3 (4.3)
|
8 (6.1)
|
|
Negative
|
17 (94.4)
|
13 (81.2)
|
27 (96.4)
|
57 (91.9)
|
67 (95.7)
|
124 (93.9)
|
|
U. parvum
|
|
Positive
|
6 (33.3)
|
12 (75.0)
|
14 (50.0)
|
32 (51.6)
|
35 (50.0)
|
67 (50.8)
|
|
Negative
|
12 (66.7)
|
4 (25.0)
|
14 (50.0)
|
30 (48.4)
|
35 (50.0)
|
65 (49.2)
|
|
U. parvum – serotype 1
|
|
Positive
|
0 (0.0)
|
1 (6.2)
|
0 (0.0)
|
1 (1.6)
|
9 (12.9)
|
10 (7.6)
|
|
Negative
|
18 (100.0)
|
15 (93.8)
|
28 (100.0)
|
61 (98.4)
|
61 (87.1)
|
122 (92.4)
|
|
U. parvum serotypes 3/14
|
|
Positive
|
5 (27.8)
|
2 (12.5)
|
4 (14.3)
|
11 (17,.)
|
10 (14.3)
|
21 (15.9)
|
|
Negative
|
13 (72.2)
|
14 (87.5)
|
24 (85.7)
|
51 (82.3)
|
60 (85.7)
|
111 (84.1)
|
|
U. parvum – serotype 6
| | | | | |
|
Positive
|
0 (0.0)
|
1 (6.2)
|
0 (0.0)
|
1 (1.6)
|
17 (24.3)
|
18 (13.6)
|
|
Negative
|
18 (100.0)
|
15 (93.8)
|
28 (100.0)
|
61 (98.4)
|
53 (75.7)
|
114 (86.4)
|
|
Chlamydia trachomatis
|
|
Positive
|
1 (5.6)
|
0 (0.0)
|
1 (3.6)
|
2 (3.2)
|
1 (1.4)
|
3 (2.3)
|
|
Negative
|
17 (94.4)
|
16 (100.0)
|
27 (94.4)
|
60 (96.8)
|
69 (98.6)
|
129 (97.7)
|
|
Neisseria gonorrhoeae
|
|
Positive
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
15 (21.4)
|
15 (11.4)
|
|
Negative
|
18 (100.0)
|
16 (100.0)
|
28 (100.0)
|
62 (100.0)
|
55 (78.6)
|
117 (88.6)
|
|
Trichomonas vaginalis
|
|
Positive
|
10 (55.6)
|
10 (62.5)
|
18 (64.3)
|
38 (61.3)
|
4 (5.7)
|
42 (31.8)
|
|
Negative
|
8 (44.4)
|
6 (37.5)
|
10 (35.7)
|
24 (38.7)
|
66 (94.3)
|
90 (68.2)
|
|
Gardnerella vaginalis
|
|
Positive
|
15 (83.3)
|
15 (93.8)
|
27 (96.4)
|
57 (91.9)
|
37 (52.9)
|
94 (71.2)
|
|
Negative
|
4 (16.7)
|
1 (6.2)
|
1 (3.6)
|
5 (8.1)
|
33 (47.1)
|
38 (28.8)
|
|
qPCR
|
|
U. urealyticum
|
|
Positive
|
2 (11.1)
|
5 (31.2)
|
1 (3.6)
|
8 (12.9)
|
9 (12.9)
|
17 (12.9)
|
|
Negative
|
16 (88.9)
|
11 (68.8)
|
27 (96.4)
|
54 (87.1)
|
61 (87.1)
|
115 (87.1)
|
|
2 U. parvum
|
|
Positive
|
12 (66.7)
|
15 (93.8)
|
22 (78.6)
|
49 (79.0)
|
41 (58.6)
|
90 (68.2)
|
|
Negative
|
6 (33.3)
|
1 (6.2)
|
6 (21.4)
|
13 (21.0)
|
29 (41.4)
|
42 (31.8)
|
-
aPrevalence in all populations studied in boldface
